Clinical Observation of Plaque Psoriasis Treated with Narrow-band Ultraviolet B and Oral Acitretin
Zheng Qing-yin
Abstract
Zheng Qing-yin
Abstract
Objective:To observe the effectiveness of narrow-band ultraviolet B(NB-UVB)associated with oral acitrretin on plaque psoriasis.Methods:111 patients with plaque psoriasis were divided into 2 groups randomly,therapy group treated with oral acitretin(0.5 mg/d·kg) associated with radiation of NB-UVB three times a week,control group treated with oral acitretin only.After 4 weeks therapy,the clinical efficiency analysis was made.Results: After 4 weeks therapy,the cure rate of 92.86 % was observed in therapy group and 76.36 % in control group.There are significant difference between two groups.Conclusion:NB-UVB associated with oral acitretin is a safe and effective method to treatment with plaque psoriasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the effectiveness of narrow-band ultraviolet B(NB-UVB)associated with oral acitrretin on plaque psoriasis.Methods:111 patients with plaque psoriasis were divided into 2 groups randomly,therapy group treated with oral acitretin(0.5 mg/d·kg) associated with radiation of NB-UVB three times a week,control group treated with oral acitretin only.After 4 weeks therapy,the clinical efficiency analysis was made.Results: After 4 weeks therapy,the cure rate of 92.86 % was observed in therapy group and 76.36 % in control group.There are significant difference between two groups.Conclusion:NB-UVB associated with oral acitretin is a safe and effective method to treatment with plaque psoriasis.
Key concepts: Acitretin, Psoriasis, Medicine, Ultraviolet b, Dermatology, Plaque psoriasis, Significant difference, Ultraviolet therapy